Category Archives: SSRI Antidepressants

Featured Stories

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

SSRI Antidepressants Can Increase Patient’s Fear and Anxiety

SSRI Antidepressants Can Increase Patient’s Fear and Anxiety

For some of the millions of people worldwide who take selective serotonin re-uptake inhibitors (SSRIs) to treat depression, the drug may actually increase the patient’s fear and anxiety. This family of widely prescribed drugs includes Prozac (fluoxetine) and Zoloft (sertraline). … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants | Tagged , , , , , , , , , , , , , |

Forest Laboratories Denies Claims in Antidepressant Drug Multidistrict Litigation

  Forest Laboratories is facing claims in a multidistrict litigation (MDL) that alleges it misrepresented the efficacy of the antidepressant drugs Lexapro and Celexa for the treatment of depression in pediatric patients. Forest countered telling the Massachusetts federal court that … Continue reading

Posted in Consumer Fraud, Health Concerns, Pharmaceuticals, SSRI Antidepressants |

New Study Warns of Increased Bleeding Risk In Patients with Combined Use of Antidepressants and NSAIDs

Combining Antidepressants & NSAIDs Cause Bleeding Risks

Results of a new study from a research team in Korea indicate that the combined use of antidepressants and nonsteroidal anti-inflammatory drugs (NSAIDs), a common form of painkiller, is associated with an increased risk of intracranial bleeding. The authors write … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants | Tagged , , , , |

Following Husband’s Death, Widow’s Sues Over Allegedly Weak Warning Label on Generic Medication

A widow is suing the maker of  (paroxetine) tablets that her husband, 42 at the time of his death, took as prescribed in 2010. The widow alleges that just six paroxetine tablets led to her husband’s suicide and did not … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

SSRI Antidepressant Use in Pregnancy Tied to Autism Risk

A new study reports that boys with autism were three times more likely to have been exposed to SSRI antidepressants (selective serotonin reuptake inhibitors)  in the womb than typically developing children. Boys whose mothers took SSRIs – including Celexa (citalopram), … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants |

Maternal Use of SSRI Antidepressants Linked to Pulmonary Hypertension in Newborns

ssri-antidepressants-newborn-hypertension

New research shows that maternal use of SSRI antidepressants late in pregnancy is linked to increased risk for persistent pulmonary hypertension (PPH) in newborns. A meta-analysis of seven studies shows a significant association between PPH – increased pressure in the pulmonary arteries – in infants whose … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants |

Adipotrim XT Dietary Supplement Recalled for Undeclared Drug Ingredient

adipotrim-xt-supplement-recall

Deseo Rebajar Inc., is voluntarily recalling Adipotrim XT, a dietary supplement sold directly to customers in Fajardo, Caguas and Bayamon, Puerto Rico, and online. A U.S. Food and Drug Administration (FDA) laboratory analysis found it to contain undeclared fluoxetine, a selective … Continue reading

Posted in Health Concerns, Pharmaceuticals, Product Recalls, SSRI Antidepressants |

Study: SSRIs Use Tied to Upper GI Bleeds

ssri_tied_to_gi_tract_bleeding

The use of selective serotonin reuptake inhibitors (SSRIs) for as little as seven days presents significant increased risks for upper gastrointestinal (GI) bleeding events, according to a new study. “Consistent with previous studies, SSRIs were the only antidepressants found to … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

Study: Certain Antidepressants Linked to Increased Clostridium Difficile Risks

antidepressants-Clostridium-difficile-infections

The antidepressants mirtazapine—sold under the brands Remeron, Avanza, and Zispin—and fluoxetine (known as Prozac, Sarafem, or Fontex) have been associated with an increased risk Clostridium difficile infection (CDI), according to new research. Investigators at the University of Michigan in Ann … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

JAMA Study: Perioperative SSRI Use Associated with Increased Adverse Event Risks

SSRI-Adverse_Effects

A new study found that patients taking selective serotonin reuptake inhibitors (SSRIs) during the perioperative period (from hospitalization admission to discharge) were at increased risks for suffering an adverse event. The study appears in the April 29, 2013 issue of … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.